HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 50704,
"recordsTotal": 50704,
"next": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=completion_date&start=49800",
"previous": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=completion_date&start=49200",
"results": [
{
"registry_id": "NCT07727538",
"publication_url": "https://clinicaltrials.gov/study/NCT07727538",
"title": "An Open-Label Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Pediatric Patients With Familial Chylomicronemia Syndrome (FCS)",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ionis Pharmaceuticals, Inc.",
"sponsor_slug": "ionis-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06131502",
"publication_url": "https://clinicaltrials.gov/study/NCT06131502",
"title": "ExAblate MR-guided Focused Ultrasound Bilateral Anterior Capsulotomy for Treatment of Obsessive-Compulsive Disorder",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07662031",
"publication_url": "https://clinicaltrials.gov/study/NCT07662031",
"title": "A Phase 2 Clinical Trial of Tovecimig Plus FOLFIRI in Second Line Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07755813",
"publication_url": "https://clinicaltrials.gov/study/NCT07755813",
"title": "Evaluation of Pirfenidone as a Novel Therapeutic Strategy Against Chronic Pancreatitis.",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vikas Dudeja",
"sponsor_slug": "vikas-dudeja",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07724938",
"publication_url": "https://clinicaltrials.gov/study/NCT07724938",
"title": "Combination Tonsillectomy and Hypoglossal Nerve Stimulation for OSA Patients With Lateral Pharyngeal Collapse",
"has_exemption": false,
"start_date": "2026-09-15",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07785661",
"publication_url": "https://clinicaltrials.gov/study/NCT07785661",
"title": "A Phase 1/2, Open-Label Clinical Trial To Assess The Safety Of The Acellular Vascular Graft ATEV In Infants With Discontinuous Pulmonary Arteries Requiring Conduit Placement",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Joseph Dearani",
"sponsor_slug": "joseph-dearani",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07303868",
"publication_url": "https://clinicaltrials.gov/study/NCT07303868",
"title": "The Use of High Bile-Binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations: A Novel Intervention for Children at Risk for Aspiration-Associated Complications (Aim 2)",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Children’s Hospital",
"sponsor_slug": "boston-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07790913",
"publication_url": "https://clinicaltrials.gov/study/NCT07790913",
"title": "Obesity Treatment Using Phentermine-Topiramate ER to Improve Metabolic Health in Adolescents and Young Adults Surviving Leukemia and Lymphoma",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07686692",
"publication_url": "https://clinicaltrials.gov/study/NCT07686692",
"title": "Iron Needed for Function and Undesirable Symptoms in Elderly With Heart Failure With Preserved Ejection Fraction",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07859423",
"publication_url": "https://clinicaltrials.gov/study/NCT07859423",
"title": "A Phase 2/3, Double-blind, Randomized, Placebo-Controlled, Multicenter, Efficacy, Safety, and Pharmacokinetics Study of AG-236 in Subjects With Polycythemia Vera",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Agios Pharmaceuticals, Inc.",
"sponsor_slug": "agios-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07805785",
"publication_url": "https://clinicaltrials.gov/study/NCT07805785",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel Group Study of Efficacy and Safety of Treprostinil Palmitil Inhalation Powder in Participants With Progressive Pulmonary Fibrosis (PPF)-PALM-PPF",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2030-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Insmed Incorporated",
"sponsor_slug": "insmed-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03932461",
"publication_url": "https://clinicaltrials.gov/study/NCT03932461",
"title": "Vacuum Assisted Closure Versus On-demand Relaparotomy in Patients With Fecal or Diffuse Peritonitis: A Multicenter Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2020-06-01",
"completion_date": "2030-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Odense University Hospital",
"sponsor_slug": "odense-university-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05989802",
"publication_url": "https://clinicaltrials.gov/study/NCT05989802",
"title": "Rapid Research in Diagnostics Development for Tuberculosis Network (R2D2 Kids) and Assessing Diagnostics At Point-of-care for Tuberculosis in Children (ADAPT for Kids)",
"has_exemption": false,
"start_date": "2024-01-26",
"completion_date": "2030-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06841679",
"publication_url": "https://clinicaltrials.gov/study/NCT06841679",
"title": "A Multi-national, Open-label, Randomized Phase II/III Clinical Study of Utidelone Capsule (UTD2) Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma",
"has_exemption": false,
"start_date": "2025-08-28",
"completion_date": "2030-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Beijing Biostar Pharmaceuticals Co., Ltd.",
"sponsor_slug": "beijing-biostar-pharmaceuticals-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07164131",
"publication_url": "https://clinicaltrials.gov/study/NCT07164131",
"title": "Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams",
"has_exemption": false,
"start_date": "2025-09-15",
"completion_date": "2030-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06827990",
"publication_url": "https://clinicaltrials.gov/study/NCT06827990",
"title": "Evaluation of the GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections",
"has_exemption": false,
"start_date": "2025-09-22",
"completion_date": "2030-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "W.L.Gore & Associates",
"sponsor_slug": "wlgore-associates",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07153003",
"publication_url": "https://clinicaltrials.gov/study/NCT07153003",
"title": "Efficacy And Safety Of Tramadol And Oxycodone Versus Oxycodone Monotherapy For Pain Control After Primary Total Knee And Total Hip Arthroplasty: A Prospective Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2026-02-02",
"completion_date": "2030-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07228624",
"publication_url": "https://clinicaltrials.gov/study/NCT07228624",
"title": "Peri-Hematopoietic Cell Transplantation Ruxolitinib in Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes",
"has_exemption": false,
"start_date": "2026-02-04",
"completion_date": "2030-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07746388",
"publication_url": "https://clinicaltrials.gov/study/NCT07746388",
"title": "Adaptive Chemotherapy for Pd-l1 High REsEctablE NSCLC: A Chemo-PHREE Trial",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2030-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Maryland, Baltimore",
"sponsor_slug": "university-of-maryland-baltimore",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07811297",
"publication_url": "https://clinicaltrials.gov/study/NCT07811297",
"title": "Phase 1b/2a Clinical Study of Catequentinib Hydrochloride (AL3818) Monotherapy or Combining Therapy With Other Anti-tumor Agents in Advanced, Metastatic Endometrial, Low Grade Serous Ovarian Cancer (LGSOC), STS or GBM Cancers",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2030-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Advenchen Pharmaceuticals, LLC.",
"sponsor_slug": "advenchen-pharmaceuticals-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07811232",
"publication_url": "https://clinicaltrials.gov/study/NCT07811232",
"title": "Phase 1b/2a Clinical Study of AL58805 Combining With Other Anti-tumor Agents in Advanced, Metastatic GYN, STS or Breast Cancers",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2030-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Advenchen Pharmaceuticals, LLC.",
"sponsor_slug": "advenchen-pharmaceuticals-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06794944",
"publication_url": "https://clinicaltrials.gov/study/NCT06794944",
"title": "Use of Fidaxomicin Compared to Vancomycin for Decolonization of C. Difficile in Patients With Inflammatory Bowel Disease",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2030-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07073391",
"publication_url": "https://clinicaltrials.gov/study/NCT07073391",
"title": "Laminar Circuit Motifs for Working Memory and Language Combinatorics: From Cells to Systems",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2030-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Christopher I. Petkov",
"sponsor_slug": "christopher-i-petkov",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07795255",
"publication_url": "https://clinicaltrials.gov/study/NCT07795255",
"title": "Effectiveness of Medical and Environmental Interventions to Reduce Cystoscopy Discomfort (CystoDiscomfort)",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2030-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Florian Schroeck",
"sponsor_slug": "florian-schroeck",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06525389",
"publication_url": "https://clinicaltrials.gov/study/NCT06525389",
"title": "Liposomal Amphotericin B and Flucytosine Antifungal Strategy for Talaromycosis (LAmB-FAST)",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2030-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07470489",
"publication_url": "https://clinicaltrials.gov/study/NCT07470489",
"title": "A Multi-Center Single-Arm Phase 2 Trial Of Zanzalintinib In Combination With Cemiplimab In BRAF Wild-Type Anaplastic Thyroid Cancer: The ZEPHYR Trial",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2030-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07797036",
"publication_url": "https://clinicaltrials.gov/study/NCT07797036",
"title": "Postpartum Semaglutide to Reduce Cardiometabolic Risk After Gestational Diabetes: An Effectiveness-Implementation Hybrid Type 1 Randomized Trial",
"has_exemption": false,
"start_date": "2027-09-01",
"completion_date": "2030-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Massachusetts, Worcester",
"sponsor_slug": "university-of-massachusetts-worcester",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05987241",
"publication_url": "https://clinicaltrials.gov/study/NCT05987241",
"title": "MODERN: An Integrated Phase 2/3 and Phase 3 Trial of MRD-Based Optimization of ADjuvant ThErapy in URothelial CaNcer",
"has_exemption": false,
"start_date": "2024-02-02",
"completion_date": "2030-09-02",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06577025",
"publication_url": "https://clinicaltrials.gov/study/NCT06577025",
"title": "A Phase 2, Open-label Study to Evaluate the Efficacy and Safety of Different Sequences of Ciltacabtagene Autoleucel (Cilta-cel), Talquetamab SC in Combination With Daratumumab SC (Tal-D) and Teclistamab SC in Combination With Daratumumab SC (Tec-D) Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) in Participants With Standard-risk Newly Diagnosed Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-08-20",
"completion_date": "2030-09-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07630714",
"publication_url": "https://clinicaltrials.gov/study/NCT07630714",
"title": "A Multicenter, Open-Label, Phase II Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Systemic Lupus Erythematosus",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2030-09-02",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07665450",
"publication_url": "https://clinicaltrials.gov/study/NCT07665450",
"title": "A Phase 3 Randomized Study Comparing Ramantamig Plus Daratumumab Versus Investigator's Choice of Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy",
"has_exemption": false,
"start_date": "2026-09-09",
"completion_date": "2030-09-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04246086",
"publication_url": "https://clinicaltrials.gov/study/NCT04246086",
"title": "A Phase Ib/II, Open-Label, Multicenter Study With a Non-Randomized Stage Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab Plus Lenalidomide (+Len), and a Randomized Stage Evaluating the Safety, Tolerability, and Pharmacokinetics of SC Versus IV Mosunetuzumab + Len in Patients With Follicular Lymphoma",
"has_exemption": false,
"start_date": "2020-08-12",
"completion_date": "2030-09-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07470879",
"publication_url": "https://clinicaltrials.gov/study/NCT07470879",
"title": "A PHASE 2 OPEN-LABEL, SINGLE ARM STUDY TO EVALUATE THE EFFICACY, PHARMACOKINETICS, AND SAFETY OF ETRASIMOD IN PEDIATRIC PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS",
"has_exemption": false,
"start_date": "2026-05-28",
"completion_date": "2030-09-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03068442",
"publication_url": "https://clinicaltrials.gov/study/NCT03068442",
"title": "Amyloid Deposition and Preexisting Vulnerable Carotid Plaque Features Predicting Cognitive Improvement After Surgery",
"has_exemption": false,
"start_date": "2017-02-17",
"completion_date": "2030-09-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Scott Mcnally",
"sponsor_slug": "scott-mcnally",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07720284",
"publication_url": "https://clinicaltrials.gov/study/NCT07720284",
"title": "A Phase III, Open-Label, Randomised, Multicentre, Global Study of Adjuvant Datopotamab Deruxtecan in Combination With Rilvegostomig in Participants With High-risk Muscle Invasive Urothelial Carcinoma",
"has_exemption": false,
"start_date": "2026-07-16",
"completion_date": "2030-09-11",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05357378",
"publication_url": "https://clinicaltrials.gov/study/NCT05357378",
"title": "Safety and Effectiveness of the Hip Innovation Technology Reverse Hip Replacement System in Primary Total Hip Arthroplasty: A Pivotal Study",
"has_exemption": false,
"start_date": "2022-07-15",
"completion_date": "2030-09-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Hip Innovation Technology",
"sponsor_slug": "hip-innovation-technology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07861100",
"publication_url": "https://clinicaltrials.gov/study/NCT07861100",
"title": "Zenagamtide Use for the Reduction of Risk of Major Adverse Cardiovascular Events in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity",
"has_exemption": false,
"start_date": "2026-10-26",
"completion_date": "2030-09-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07361497",
"publication_url": "https://clinicaltrials.gov/study/NCT07361497",
"title": "ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Compared to Durvalumab in Participants With Unresectable Stage III NSCLC Without Progression After Platinum-based Concurrent Chemoradiation Therapy.",
"has_exemption": false,
"start_date": "2026-03-16",
"completion_date": "2030-09-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07856420",
"publication_url": "https://clinicaltrials.gov/study/NCT07856420",
"title": "A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Trial to Assess the Efficacy, Safety, and Tolerability of JNJ-99245354 (ITI-1284) as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder Who Have an Inadequate Response to Generalized Anxiety Disorder Treatment and an Open-label Long-term Extension Treatment With JNJ-99245354 (ITI-1284)",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2030-09-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Intra-Cellular Therapies, Inc.",
"sponsor_slug": "intra-cellular-therapies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07181109",
"publication_url": "https://clinicaltrials.gov/study/NCT07181109",
"title": "ZENITH: A Phase 3 Global, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Zilebesiran in Addition to Standard of Care in Reducing Major Adverse Cardiovascular Events in Adult Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease",
"has_exemption": false,
"start_date": "2025-09-06",
"completion_date": "2030-09-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Alnylam Pharmaceuticals",
"sponsor_slug": "alnylam-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07456033",
"publication_url": "https://clinicaltrials.gov/study/NCT07456033",
"title": "The MODIFY Study: A Phase 3b/4 Randomized, Double-blind, Placebo-controlled, Multi-centre Study Evaluating the Impact of Early Intervention With Depemokimab on Exacerbation Rate, Clinical Remission, Lung Function Decline, and Safety in Adults and Adolescents With at Risk Type 2 Asthma, Conducted up to 156 Weeks",
"has_exemption": false,
"start_date": "2026-03-13",
"completion_date": "2030-09-23",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07872553",
"publication_url": "https://clinicaltrials.gov/study/NCT07872553",
"title": "Subcutaneous Versus Intravenous Immune Checkpoint Inhibitors, Treatment Burden, and Care Delivery for Patients With Renal Cell Carcinoma",
"has_exemption": false,
"start_date": "2026-09-24",
"completion_date": "2030-09-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06716606",
"publication_url": "https://clinicaltrials.gov/study/NCT06716606",
"title": "An Open Label Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD)",
"has_exemption": false,
"start_date": "2024-12-12",
"completion_date": "2030-09-27",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07173803",
"publication_url": "https://clinicaltrials.gov/study/NCT07173803",
"title": "The Progressive Supranuclear Palsy Clinical Trial Platform",
"has_exemption": false,
"start_date": "2026-07-29",
"completion_date": "2030-09-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Adam Boxer",
"sponsor_slug": "adam-boxer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07217665",
"publication_url": "https://clinicaltrials.gov/study/NCT07217665",
"title": "The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1",
"has_exemption": false,
"start_date": "2026-07-29",
"completion_date": "2030-09-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Adam Boxer",
"sponsor_slug": "adam-boxer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07264283",
"publication_url": "https://clinicaltrials.gov/study/NCT07264283",
"title": "The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31",
"has_exemption": false,
"start_date": "2026-07-29",
"completion_date": "2030-09-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Adam Boxer",
"sponsor_slug": "adam-boxer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00525720",
"publication_url": "https://clinicaltrials.gov/study/NCT00525720",
"title": "Transperineal Interstitial Permanent Brachytherapy Alone for Selected Patients With Intermediate Risk Prostatic Carcinoma",
"has_exemption": false,
"start_date": "2006-08-01",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02559778",
"publication_url": "https://clinicaltrials.gov/study/NCT02559778",
"title": "A Study Using Molecular Guided Therapy With Induction Chemotherapy Followed by a Randomized Controlled Trial of Standard Immunotherapy With or Without DFMO Followed by DFMO Maintenance for Newly Diagnosed High-Risk Neuroblastoma",
"has_exemption": false,
"start_date": "2015-09-30",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Giselle Sholler",
"sponsor_slug": "giselle-sholler",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03143374",
"publication_url": "https://clinicaltrials.gov/study/NCT03143374",
"title": "Positron Emission Tomography (PET) Imaging of Tau Pathology in Neurodegenerative Disease",
"has_exemption": false,
"start_date": "2016-08-23",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03034811",
"publication_url": "https://clinicaltrials.gov/study/NCT03034811",
"title": "Persona Partial Knee Clinical Outcomes Study",
"has_exemption": false,
"start_date": "2017-02-08",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03424005",
"publication_url": "https://clinicaltrials.gov/study/NCT03424005",
"title": "A Phase Ib/II, Open-label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic Breast Cancer (Morpheus-panBC)",
"has_exemption": false,
"start_date": "2018-03-30",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03126916",
"publication_url": "https://clinicaltrials.gov/study/NCT03126916",
"title": "A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or ALK Inhibitor Therapy Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)",
"has_exemption": false,
"start_date": "2018-05-14",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04685616",
"publication_url": "https://clinicaltrials.gov/study/NCT04685616",
"title": "A Randomised Phase III Trial With a PET Response Adapted Design Comparing ABVD +/- ISRT With A2VD +/- ISRT in Patients With Previously Untreated Stage IA/IIA Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2022-04-14",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University College, London",
"sponsor_slug": "university-college-london",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05450653",
"publication_url": "https://clinicaltrials.gov/study/NCT05450653",
"title": "Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Fetuses With Severe Congenital Diaphragmatic Hernia (CDH)",
"has_exemption": false,
"start_date": "2022-09-18",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Aimen F. Shaaban, MD",
"sponsor_slug": "aimen-f-shaaban-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04858009",
"publication_url": "https://clinicaltrials.gov/study/NCT04858009",
"title": "A Phase II Study of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients With Pancreatic Cancer and Peritoneal Metastasis",
"has_exemption": false,
"start_date": "2024-02-15",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06441955",
"publication_url": "https://clinicaltrials.gov/study/NCT06441955",
"title": "Covid-19 Long Haul Syndrome: Undiagnosed Disorder Post Covid-19 Alternative Treatment Study.",
"has_exemption": false,
"start_date": "2024-03-01",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Well- Konnect Healthcare Services and Research Firm",
"sponsor_slug": "well-konnect-healthcare-services-and-research-firm",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06264180",
"publication_url": "https://clinicaltrials.gov/study/NCT06264180",
"title": "Randomized, Ph3 Clinical Study Comparing Vusolimogene Oderparepvec in Combination With Nivolumab Vs Treatment of Physician's Choice in Patients With Advanced Melanoma That Progressed on Anti-PD-1 and Anti-CTLA-4 Containing Treatment [IGNYTE-3]",
"has_exemption": false,
"start_date": "2024-07-11",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Replimune Inc.",
"sponsor_slug": "replimune-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05673018",
"publication_url": "https://clinicaltrials.gov/study/NCT05673018",
"title": "REACH Study: Galleri® in the Medicare Population.",
"has_exemption": false,
"start_date": "2024-07-12",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "GRAIL, Inc.",
"sponsor_slug": "grail-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06475989",
"publication_url": "https://clinicaltrials.gov/study/NCT06475989",
"title": "A Randomized Phase III Study of BRAF-Targeted Therapy vs Cabozantinib in RAI-Refractory Differentiated Thyroid Cancer With BRAF V600Em",
"has_exemption": false,
"start_date": "2024-12-27",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06518785",
"publication_url": "https://clinicaltrials.gov/study/NCT06518785",
"title": "Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder",
"has_exemption": false,
"start_date": "2025-01-07",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06861244",
"publication_url": "https://clinicaltrials.gov/study/NCT06861244",
"title": "PNOC031: Protocol for Embryonal Tumor With Multilayered Rosettes (ETMR)",
"has_exemption": false,
"start_date": "2025-03-06",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06953882",
"publication_url": "https://clinicaltrials.gov/study/NCT06953882",
"title": "SELECT: A Phase II Adjuvant Trial Evaluating the Impact of Omitting Chemotherapy Based on Patient's Selection for Moderate to High-Anatomical Risk, Low-Genomic Risk, ER-Positive, HER2- Negative Breast Cancer With a Combination Regimen of Ribociclib and Optimized Endocrine Therapy",
"has_exemption": false,
"start_date": "2025-07-09",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07096362",
"publication_url": "https://clinicaltrials.gov/study/NCT07096362",
"title": "A Phase 2 Study Assessing Utility of ctDNA in Early Switch of First-line Chemotherapy in Metastatic Pancreatic Ductal Adenocarcinoma",
"has_exemption": false,
"start_date": "2025-09-09",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06997081",
"publication_url": "https://clinicaltrials.gov/study/NCT06997081",
"title": "Elranatamab, Lenalidomide, Dexamethasone in Newly Diagnosed Multiple Myeloma, a Clinical and Correlative Phase 2 Study",
"has_exemption": false,
"start_date": "2025-09-16",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07158476",
"publication_url": "https://clinicaltrials.gov/study/NCT07158476",
"title": "Efficacy of Methylprednisolone for Pain Control After ACL Repair: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-10-21",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Louis University",
"sponsor_slug": "st-louis-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07214207",
"publication_url": "https://clinicaltrials.gov/study/NCT07214207",
"title": "Orexin Receptor Antagonism for the Treatment of Alcohol Use Disorder and Stress-Related Drinking",
"has_exemption": false,
"start_date": "2025-12-04",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University",
"sponsor_slug": "ohio-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07155187",
"publication_url": "https://clinicaltrials.gov/study/NCT07155187",
"title": "A Phase 2/3 Open Label Randomized Study of Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Subjects With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer After Progression on a Third-Generation EGFR TKI - AndroMETa-Lung-713",
"has_exemption": false,
"start_date": "2025-12-10",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07424846",
"publication_url": "https://clinicaltrials.gov/study/NCT07424846",
"title": "Xylitol and the Prevention of Periodontal Disease and Preterm Birth (XaPPP) Trial",
"has_exemption": false,
"start_date": "2026-03-26",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07225985",
"publication_url": "https://clinicaltrials.gov/study/NCT07225985",
"title": "Pralatrexate and Bendamustine With 3 Gy TBI as a New Reduced Intensity Conditioning (RIC) Regimen for Allogeneic HCT for T-Cell Lymphoma Patients Who Are in Untreated R/R, or in Remission With MRD",
"has_exemption": false,
"start_date": "2026-04-27",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07365241",
"publication_url": "https://clinicaltrials.gov/study/NCT07365241",
"title": "A Phase 3 Randomized, Open Label, Multicenter Study to Evaluate the Safety and Efficacy of ABBV-706 Versus Standard of Care in Subjects With Relapsed/Refractory Small Cell Lung Cancer (SCLC)",
"has_exemption": false,
"start_date": "2026-07-02",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07088120",
"publication_url": "https://clinicaltrials.gov/study/NCT07088120",
"title": "PRecision-Controlled Ventilation to Enhance Cardiac Arrest Intervention and Survival IN CPR: A Multi-Center Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rush University Medical Center",
"sponsor_slug": "rush-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07218575",
"publication_url": "https://clinicaltrials.gov/study/NCT07218575",
"title": "A Randomized, Placebo Controlled Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Children’s Hospital",
"sponsor_slug": "boston-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07642635",
"publication_url": "https://clinicaltrials.gov/study/NCT07642635",
"title": "Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular Dystrophy",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07747311",
"publication_url": "https://clinicaltrials.gov/study/NCT07747311",
"title": "Dual-focus Soft Contact Lenses for the Treatment of Adult Myopia Progression",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Berkeley",
"sponsor_slug": "university-of-california-berkeley",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07485335",
"publication_url": "https://clinicaltrials.gov/study/NCT07485335",
"title": "Implementation and Effectiveness of A Bundled Intervention to End Opioid Overdoses by Increasing Treatment Uptake Post Discharge",
"has_exemption": false,
"start_date": "2026-09-07",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07570940",
"publication_url": "https://clinicaltrials.gov/study/NCT07570940",
"title": "Effectiveness Of Liposomal Bupivacaine Stellate Ganglion Blockade In Preventing Atrial Fibrillation After Isolated Coronary Artery Bypass Grafting Surgery: A Randomized Placebo-Controlled Trial",
"has_exemption": false,
"start_date": "2026-09-14",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07730528",
"publication_url": "https://clinicaltrials.gov/study/NCT07730528",
"title": "A Phase 2a Study for the Evaluation of Safety and Efficacy of Humacyte's Coronary Tissue Engineered Vessel (CTEV) as a Vascular Conduit for Coronary Artery Bypass Grafting in Patients With Coronary Artery Disease",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Humacyte, Inc.",
"sponsor_slug": "humacyte-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07762703",
"publication_url": "https://clinicaltrials.gov/study/NCT07762703",
"title": "Phase 1/2 Trial of a Combination Immunotherapy Treatment for Solid Tumors Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BreakBio Corp",
"sponsor_slug": "breakbio-corp",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07762794",
"publication_url": "https://clinicaltrials.gov/study/NCT07762794",
"title": "A Phase 4 Observational Multicenter Study to Evaluate the Safety and Efficacy of SYMVESS™ in a Real World Setting for Arterial Replacement or Reconstruction in Patients With Extremity Vascular Trauma",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Humacyte, Inc.",
"sponsor_slug": "humacyte-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07762716",
"publication_url": "https://clinicaltrials.gov/study/NCT07762716",
"title": "Phase 1/2 Trial of a Combination Immunotherapy Treatment for Solid Tumors Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BreakBio Corp",
"sponsor_slug": "breakbio-corp",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07337655",
"publication_url": "https://clinicaltrials.gov/study/NCT07337655",
"title": "A Phase II/III Clinical Trial Evaluating the Efficacy and Safety of Aspirin and Lansoprazole in High-Risk Pregnant Women for the Prevention of Preterm Birth: A Biomarker-Enriched Design",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07583745",
"publication_url": "https://clinicaltrials.gov/study/NCT07583745",
"title": "Phase 2 Study of EPN-701 for the Treatment of Calciphylaxis",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sagar U. Nigwekar, MD, MMSc",
"sponsor_slug": "sagar-u-nigwekar-md-mmsc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07152379",
"publication_url": "https://clinicaltrials.gov/study/NCT07152379",
"title": "An Open-label, Controlled Phase 2 Study Assessing a Challenge Transfusion of INTERCEPT Pathogen Reduced Red Blood Cells (RBCs) in Subjects With or Without Pre-existing Antibodies to INTERCEPT RBCs",
"has_exemption": false,
"start_date": "2026-10-10",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Cerus Corporation",
"sponsor_slug": "cerus-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07167940",
"publication_url": "https://clinicaltrials.gov/study/NCT07167940",
"title": "RAPID5: Rapid Acceleration Process for Intensive Treatment of PTSD in 5 Days",
"has_exemption": false,
"start_date": "2026-11-16",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07674745",
"publication_url": "https://clinicaltrials.gov/study/NCT07674745",
"title": "Study of Therapeutic Plasma Exchange, Rituximab, and Intravenous Immunoglobulin for Progressive Idiopathic Pulmonary Fibrosis (STRIVE II)",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07703436",
"publication_url": "https://clinicaltrials.gov/study/NCT07703436",
"title": "A Phase 2, Multicenter, Clinical Study to Evaluate the Efficacy and Safety of Safusidenib Erbumine in Participants With Isocitrate Dehydrogenase 1 (IDH1)-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease",
"has_exemption": false,
"start_date": "2027-03-31",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Nuvation Bio, Inc.",
"sponsor_slug": "nuvation-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07722988",
"publication_url": "https://clinicaltrials.gov/study/NCT07722988",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Investigating the Efficacy and Safety of Roxadustat (FG-4592) for Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) in Participants With High Red Blood Cell Transfusion Burden",
"has_exemption": false,
"start_date": "2027-04-30",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Kyntra Bio",
"sponsor_slug": "kyntra-bio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07835555",
"publication_url": "https://clinicaltrials.gov/study/NCT07835555",
"title": "Smoking Cessation Medication And Rewards Using a Teamlet to Treat Tobacco Use Disorder (SMARTTT 2.0) Among Persons With HIV: A Multi-site Hybrid Type 2 Effectiveness-implementation Trial",
"has_exemption": false,
"start_date": "2027-09-30",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07787585",
"publication_url": "https://clinicaltrials.gov/study/NCT07787585",
"title": "Discontinuation of Low Dose Levothyroxine Therapy for Older Adults With Subclinical Hypothyroidism: a Randomized, Double-blinded, Placebo-controlled Study",
"has_exemption": false,
"start_date": "2027-10-31",
"completion_date": "2030-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Spyridoula Maraka",
"sponsor_slug": "spyridoula-maraka",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06034821",
"publication_url": "https://clinicaltrials.gov/study/NCT06034821",
"title": "Rapid Reversal of Suicidal Depression: Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan (REaKT-SD)",
"has_exemption": false,
"start_date": "2023-10-01",
"completion_date": "2030-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07240922",
"publication_url": "https://clinicaltrials.gov/study/NCT07240922",
"title": "The Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE III) Study - a Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2030-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Hong Kong",
"sponsor_slug": "the-university-of-hong-kong",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06942442",
"publication_url": "https://clinicaltrials.gov/study/NCT06942442",
"title": "A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma",
"has_exemption": false,
"start_date": "2025-10-22",
"completion_date": "2030-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Sarcoma Alliance for Research through Collaboration",
"sponsor_slug": "sarcoma-alliance-for-research-through-collaboration",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07075510",
"publication_url": "https://clinicaltrials.gov/study/NCT07075510",
"title": "A Phase I/II Study of Subcutaneous Daratumumab Administration in the Anterior Upper Thigh Vs Abdomen in Patients With Plasma Cell Disorders",
"has_exemption": false,
"start_date": "2025-10-23",
"completion_date": "2030-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Maryland, Baltimore",
"sponsor_slug": "university-of-maryland-baltimore",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07209189",
"publication_url": "https://clinicaltrials.gov/study/NCT07209189",
"title": "Neoadjuvant Chemotherapy and PD-1 Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)",
"has_exemption": false,
"start_date": "2026-02-18",
"completion_date": "2030-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07706673",
"publication_url": "https://clinicaltrials.gov/study/NCT07706673",
"title": "A Scientific Evaluation of One or Two Doses of a Vaccine Against Human Papillomavirus: Long Term Follow Up of Gardasil9 Recipients in the ESCUDDO Study (\"Estudio de Comparación de Una y Dos Dosis de Vacunas Contra el Virus de Papiloma Humano (VPH)\")",
"has_exemption": false,
"start_date": "2026-08-11",
"completion_date": "2030-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07789912",
"publication_url": "https://clinicaltrials.gov/study/NCT07789912",
"title": "A Phase II Study Assessing the Efficacy of BRain-AVOidant Proton Craniospinal Irradiation (CSI) for Leptomeningeal Metastases (LM) From Solid Tumor Malignancies (BRAVO-LM)",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2030-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07812181",
"publication_url": "https://clinicaltrials.gov/study/NCT07812181",
"title": "An Open-Label Phase II Feasibility Study for the Use of Ublituximab in Adults With Down Syndrome Regression Disorder",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2030-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonathan Santoro",
"sponsor_slug": "jonathan-santoro",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07098364",
"publication_url": "https://clinicaltrials.gov/study/NCT07098364",
"title": "A Phase 1/2 Open-Label Study Evaluating the Safety and Efficacy of ST-067 in Combination With CD19-Directed CAR T-Cell Therapy in Patients With Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL)",
"has_exemption": false,
"start_date": "2025-12-27",
"completion_date": "2030-10-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07753993",
"publication_url": "https://clinicaltrials.gov/study/NCT07753993",
"title": "A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled Multicenter Study to Evaluate the Effect of Elecoglipron in Reducing Renal Outcomes and Mortality in Participants With Chronic Kidney Disease (Elevate-CKD)",
"has_exemption": false,
"start_date": "2026-08-21",
"completion_date": "2030-10-04",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07192237",
"publication_url": "https://clinicaltrials.gov/study/NCT07192237",
"title": "Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia",
"has_exemption": false,
"start_date": "2026-04-21",
"completion_date": "2030-10-12",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04270409",
"publication_url": "https://clinicaltrials.gov/study/NCT04270409",
"title": "A Phase 3 Randomized, Open-label, Multicenter Study of Isatuximab (SAR650984) in Combination With Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With High-risk Smoldering Multiple Myeloma",
"has_exemption": false,
"start_date": "2020-06-16",
"completion_date": "2030-10-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06525766",
"publication_url": "https://clinicaltrials.gov/study/NCT06525766",
"title": "Single Arm Pilot Trial of Adaptive Therapy (AT) With Capecitabine for the Treatment of Metastatic Estrogen Receptor Positive, Hormone Refractory Breast Cancer",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2030-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07704892",
"publication_url": "https://clinicaltrials.gov/study/NCT07704892",
"title": "A Phase 3, Two-part, Double-blind, Randomized, Placebo-controlled Study to Investigate the Safety and Efficacy of Efimosfermin Alfa Injection in Adult Participants With Compensated Cirrhosis (Stage F4 Fibrosis) Due to Metabolic Dysfunction-associated Steatohepatitis (NEBULA-2)",
"has_exemption": false,
"start_date": "2026-07-22",
"completion_date": "2030-10-16",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05623020",
"publication_url": "https://clinicaltrials.gov/study/NCT05623020",
"title": "AN OPEN-LABEL, 2-ARM, MULTICENTER, RANDOMIZED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ELRANATAMAB (PF-06863135) + DARATUMUMAB + LENALIDOMIDE VERSUS DARATUMUMAB + BORTEZOMIB + LENALIDOMIDE + DEXAMETHASONE IN TRANSPLANT-INELIGIBLE PARTICIPANTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA",
"has_exemption": false,
"start_date": "2022-11-10",
"completion_date": "2030-10-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06669117",
"publication_url": "https://clinicaltrials.gov/study/NCT06669117",
"title": "A First-In-Human (FIH) Phase I/II Open-label, Multicentre, Dose Escalation and Expansion Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors Including Non-small Cell Lung Cancer (NSCLC) Harboring Mesenchymal-Epithelial Transition (MET) Alterations",
"has_exemption": false,
"start_date": "2024-10-22",
"completion_date": "2030-10-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Pierre Fabre Medicament",
"sponsor_slug": "pierre-fabre-medicament",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04545957",
"publication_url": "https://clinicaltrials.gov/study/NCT04545957",
"title": "Judging MR Simulation Procedures: A Phase I-II Study of the Use of Magnetic Resonance Imaging Simulation in the Planning of Radiation Treatments",
"has_exemption": false,
"start_date": "2020-10-14",
"completion_date": "2030-10-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06646289",
"publication_url": "https://clinicaltrials.gov/study/NCT06646289",
"title": "An Open-label, Multicenter, Phase 2 Follow-on Study for Second Eye Treatment of Patients Previously Treated With a Recombinant Adeno-associated Virus Vector (AAV5 hRKp.RPGR) for Gene Therapy of Adults and Children With X-linked Retinitis Pigmentosa Owing to Defects in Retinitis Pigmentosa GTPase Regulator (RPGR)",
"has_exemption": false,
"start_date": "2024-10-10",
"completion_date": "2030-10-24",
"has_results": false,
"results_due": false,
"sponsor_name": "MeiraGTx Ocular UK Ltd",
"sponsor_slug": "meiragtx-ocular-uk-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07363694",
"publication_url": "https://clinicaltrials.gov/study/NCT07363694",
"title": "AN INTERVENTIONAL PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, THIRD PARTY-UNBLINDED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO INVESTIGATE EFFICACY AND SAFETY OF PF-07275315 IN ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)",
"has_exemption": false,
"start_date": "2026-02-11",
"completion_date": "2030-10-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07468136",
"publication_url": "https://clinicaltrials.gov/study/NCT07468136",
"title": "Phase I/IIa Trial of Retifanlimab and Difluoromethylornithine (DFMO) in Patients With Progressive High-Grade Glioma",
"has_exemption": false,
"start_date": "2026-06-23",
"completion_date": "2030-10-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07594106",
"publication_url": "https://clinicaltrials.gov/study/NCT07594106",
"title": "Phase 1/2 Study of REGN15505 (a PSMAx4-1BB Bispecific Antibody) Administered Alone or in Combination With Cemiplimab or REGN4336 (a PSMAxCD3 Bispecific Antibody) in Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma",
"has_exemption": false,
"start_date": "2026-07-20",
"completion_date": "2030-10-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05920798",
"publication_url": "https://clinicaltrials.gov/study/NCT05920798",
"title": "MC220601, Folate Receptor Alpha Dendritic Cells (FRαDCs) Plus Pembrolizumab for Patients With Advanced Stage Ovarian Cancer (FRAPPE)",
"has_exemption": false,
"start_date": "2023-09-28",
"completion_date": "2030-10-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222956",
"publication_url": "https://clinicaltrials.gov/study/NCT07222956",
"title": "An Open-label, Single-center Study of Remibrutinib Using Ultra High-field (7T) MR Imaging in Relapsing or Progressive MS (RemiSeven)",
"has_exemption": false,
"start_date": "2027-03-01",
"completion_date": "2030-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Moein Amin",
"sponsor_slug": "moein-amin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00160732",
"publication_url": "https://clinicaltrials.gov/study/NCT00160732",
"title": "Allogenic Islet Cells (Human, U. of Chicago) Administered Via Intraportal Infusion; and Immunosuppressive Therapy",
"has_exemption": false,
"start_date": "2003-10-31",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02015013",
"publication_url": "https://clinicaltrials.gov/study/NCT02015013",
"title": "Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models",
"has_exemption": false,
"start_date": "2014-01-15",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04584853",
"publication_url": "https://clinicaltrials.gov/study/NCT04584853",
"title": "PreOperative Endocrine Therapy for Individualised Care With Abemaciclib",
"has_exemption": false,
"start_date": "2020-12-23",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Institute of Cancer Research, United Kingdom",
"sponsor_slug": "institute-of-cancer-research-united-kingdom",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04948619",
"publication_url": "https://clinicaltrials.gov/study/NCT04948619",
"title": "Immune Function and Response to Vaccination Following Completion of Cancer Directed Systemic Therapy in Pediatric Patients With Cancer",
"has_exemption": false,
"start_date": "2022-08-08",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05371093",
"publication_url": "https://clinicaltrials.gov/study/NCT05371093",
"title": "A Phase 3 Randomized, Open-Label, Multicenter Study Evaluating the Efficacy of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Subjects With Relapsed/Refractory Follicular Lymphoma",
"has_exemption": false,
"start_date": "2022-09-22",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kite, A Gilead Company",
"sponsor_slug": "kite-a-gilead-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07142408",
"publication_url": "https://clinicaltrials.gov/study/NCT07142408",
"title": "The Effect of Pre-Operative Bacterial Decolonization on Post-Operative Infection Rate for Lower Extremity Wounds Healing by Second Intention",
"has_exemption": false,
"start_date": "2023-03-13",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The Cooper Health System",
"sponsor_slug": "the-cooper-health-system",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06098833",
"publication_url": "https://clinicaltrials.gov/study/NCT06098833",
"title": "Treatment of Neonatal Encephalopathy With Oral Sildenafil Suspension to Repair Brain Injury Secondary to Birth Asphyxia: A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate Safety and Efficacy (Phase II Study)",
"has_exemption": false,
"start_date": "2024-07-01",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Pia Wintermark",
"sponsor_slug": "pia-wintermark",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05933395",
"publication_url": "https://clinicaltrials.gov/study/NCT05933395",
"title": "Genetically-informed Therapy for ER+ Breast Cancer in a Post-CDK4/6 Inhibitor Setting: a Phase II Umbrella Study (GERTRUDE)",
"has_exemption": false,
"start_date": "2024-09-23",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dartmouth-Hitchcock Medical Center",
"sponsor_slug": "dartmouth-hitchcock-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06121180",
"publication_url": "https://clinicaltrials.gov/study/NCT06121180",
"title": "A Phase II Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma",
"has_exemption": false,
"start_date": "2024-11-04",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06628310",
"publication_url": "https://clinicaltrials.gov/study/NCT06628310",
"title": "A Phase 2 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination With Fluorouracil, Leucovorin, and Budigalimab as First-Line Treatment in Subjects With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (AndroMETa-GEA-977)",
"has_exemption": false,
"start_date": "2024-12-13",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07008469",
"publication_url": "https://clinicaltrials.gov/study/NCT07008469",
"title": "A Global Phase 3 Open-Label Extension Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Intravenous AOC 1001 for the Treatment of Myotonic Dystrophy Type 1",
"has_exemption": false,
"start_date": "2025-06-26",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Avidity Biosciences, Inc.",
"sponsor_slug": "avidity-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06626516",
"publication_url": "https://clinicaltrials.gov/study/NCT06626516",
"title": "A Phase I/II Study of Tebentafusp-tebn in Combination With Liver-Directed Therapies for the Treatment of Metastatic Uveal Melanoma",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Thomas Jefferson University",
"sponsor_slug": "thomas-jefferson-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07216248",
"publication_url": "https://clinicaltrials.gov/study/NCT07216248",
"title": "A Phase II Randomized, Decentralized, De-escalation Study in Patients With Metastatic Hormone-Sensitive Prostate Cancer Achieving Optimal PSA Response (OPTIMAS)",
"has_exemption": false,
"start_date": "2025-10-27",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05213676",
"publication_url": "https://clinicaltrials.gov/study/NCT05213676",
"title": "Inhaled Nitric Oxide (iNO) for Congenital Diaphragmatic Hernia (CDH) - The \"NoNO Trial\" - a Multi-center, De-implementation, Stepped-wedge, Cluster-randomized Trial Within an Established Collaborative",
"has_exemption": false,
"start_date": "2025-11-01",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07150715",
"publication_url": "https://clinicaltrials.gov/study/NCT07150715",
"title": "Alpha-Emitting Radionuclide or Beta-Emitting Radionuclide Combined With Metastasis-Directed Stereotactic Body Radiotherapy for Oligorecurrent Prostate Adenocarcinoma (ANDROMEDA)",
"has_exemption": false,
"start_date": "2025-12-12",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07265947",
"publication_url": "https://clinicaltrials.gov/study/NCT07265947",
"title": "A Phase 2A/B, Multi-center, Open-Label Study Evaluating the Efficacy and Safety of Dabogratinib (TYRA-300) in Participants With Low Grade Upper Tract Urothelial Carcinoma (SURF303)",
"has_exemption": false,
"start_date": "2025-12-22",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Tyra Biosciences, Inc",
"sponsor_slug": "tyra-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07015190",
"publication_url": "https://clinicaltrials.gov/study/NCT07015190",
"title": "A Randomized, Phase 3, Open-label Study of Neoadjuvant Darovasertib in Subjects With Primary Non-metastatic Uveal Melanoma (OptimUM-10)",
"has_exemption": false,
"start_date": "2026-01-25",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "IDEAYA Biosciences",
"sponsor_slug": "ideaya-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07599670",
"publication_url": "https://clinicaltrials.gov/study/NCT07599670",
"title": "A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of ABBV-1758 in Participants With Alzheimer's Disease",
"has_exemption": false,
"start_date": "2026-05-15",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07678775",
"publication_url": "https://clinicaltrials.gov/study/NCT07678775",
"title": "An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of BBP-418 (Ribitol) in Participants With Limb-Girdle Muscular Dystrophy 2I/R9 (LGMD2I/R9)",
"has_exemption": false,
"start_date": "2026-06-05",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ML Bio Solutions, Inc.",
"sponsor_slug": "ml-bio-solutions-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07708727",
"publication_url": "https://clinicaltrials.gov/study/NCT07708727",
"title": "An Operationally Seamless Phase 2/3 Randomized, Open-label, Active-Controlled Study Evaluating the Safety and Efficacy of an Injectable Regimen of GS-3242 in Combination With Lenacapavir Versus Biktarvy (Bictegravir/Emtricitabine/Tenofovir Alafenamide) in Treatment-Naive People With HIV-1",
"has_exemption": false,
"start_date": "2026-07-29",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07815665",
"publication_url": "https://clinicaltrials.gov/study/NCT07815665",
"title": "A Randomized Phase 2/3 Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma (HARMONi-GU1)",
"has_exemption": false,
"start_date": "2026-09-10",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Summit Therapeutics",
"sponsor_slug": "summit-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07746089",
"publication_url": "https://clinicaltrials.gov/study/NCT07746089",
"title": "Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study With an Open-Label Extension to Evaluate the Efficacy and Safety of Intravenous Adimanebart in Adult and Pediatric Participants With DOK7-,MUSK-, AGRN-, or LRP4-CMS",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07731789",
"publication_url": "https://clinicaltrials.gov/study/NCT07731789",
"title": "TREND-FL: Tafasitamab and Rituximab to Enhance Outcomes in Patients With Newly Diagnosed Follicular Lymphoma",
"has_exemption": false,
"start_date": "2026-10-09",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07528690",
"publication_url": "https://clinicaltrials.gov/study/NCT07528690",
"title": "Microbiota Transplant Therapy to Prevent HE Recurrence in a Phase 2B Multi-Center Trial of Veterans With Cirrhosis",
"has_exemption": false,
"start_date": "2026-10-30",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07580339",
"publication_url": "https://clinicaltrials.gov/study/NCT07580339",
"title": "Combining CD93 Inhibition (DCSZ11) With Short Course Radiation and Chemotherapy as Part of Total Neoadjuvant Treatment (TNT) for High-risk Mismatch Repair Proficient (pMMR) Locally Advanced Rectal Cancer (LARC)",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07619365",
"publication_url": "https://clinicaltrials.gov/study/NCT07619365",
"title": "Phase II Trial Evaluating Trastuzumab Deruxtecan and Lovastatin in HER2-low and Ultralow Advanced or Metastatic Breast Cancer (MBC)",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07737925",
"publication_url": "https://clinicaltrials.gov/study/NCT07737925",
"title": "LuX: A Feasibility Study of Xaluritamig in Participants With Metastatic Castrate Resistant Prostate Cancer and Suboptimal Response to Lutetium 177 Vipivotide Tetraxetan",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Thomas Jefferson University",
"sponsor_slug": "thomas-jefferson-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07735338",
"publication_url": "https://clinicaltrials.gov/study/NCT07735338",
"title": "Prospective Study of the Diagnostic Accuracy of a Smartphone Application to PREDICT Real-Time Cardiovascular Risk for Heart Attack and Stroke (PREDICT-HS)",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07858253",
"publication_url": "https://clinicaltrials.gov/study/NCT07858253",
"title": "CLEAR-Lung III: Circulating Tumor DNA-Guided Consolidation Chemotherapy and Immunotherapy After Chemoradiation in Unresectable Stage III NSCLC",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Anusha Chidharla, MD",
"sponsor_slug": "anusha-chidharla-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07148843",
"publication_url": "https://clinicaltrials.gov/study/NCT07148843",
"title": "Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06905626",
"publication_url": "https://clinicaltrials.gov/study/NCT06905626",
"title": "Prevention of Obesity in Adolescents and Young Adults",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07791199",
"publication_url": "https://clinicaltrials.gov/study/NCT07791199",
"title": "A Continuation Protocol for Deucravacitinib in Adult Patients With Systemic Lupus Erythematosus (SLE) or Sjögren's Disease (SjD) and Pediatric Patients With Psoriasis (PsO) or Psoriatic Arthritis (PsA) Who Have Completed Parent Studies",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03244072",
"publication_url": "https://clinicaltrials.gov/study/NCT03244072",
"title": "Safety and Efficacy of Intracameral Zimoxin (0.1% Moxifloxacin Solution) for Prevention of Endophthalmitis After Cataract Surgery",
"has_exemption": false,
"start_date": "2027-06-01",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jason Ahee, M.D.",
"sponsor_slug": "jason-ahee-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04760860",
"publication_url": "https://clinicaltrials.gov/study/NCT04760860",
"title": "a Randomized, Double Blind, Placebo Controlled Clinical Trial Exploring the Target Engagement and Tolerability of Terazosin Hydrochloride in Patients With Dementia With Lewy Bodies",
"has_exemption": false,
"start_date": "2027-10-31",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Qiang Zhang",
"sponsor_slug": "qiang-zhang",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06039202",
"publication_url": "https://clinicaltrials.gov/study/NCT06039202",
"title": "A Phase 2, Randomized, Open Label Study to Evaluate Efficacy, Safety, and Tolerability of CA102N Combined With Trifluridine/Tipiracil (TAS-102) Compared to Bevacizumab Combined With TAS-102 in Subjects With Metastatic Colorectal Cancer (mCRC) Who Failed the Standard Treatment",
"has_exemption": false,
"start_date": "2027-12-31",
"completion_date": "2030-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Holy Stone Healthcare Co., Ltd",
"sponsor_slug": "holy-stone-healthcare-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06458036",
"publication_url": "https://clinicaltrials.gov/study/NCT06458036",
"title": "Selpercatinib to Enhance RAI Avidity in Children, Adolescents, and Young Adults With Newly Diagnosed Differentiated Thyroid Cancers Harboring RET Fusions",
"has_exemption": false,
"start_date": "2024-07-29",
"completion_date": "2030-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital of Philadelphia",
"sponsor_slug": "childrens-hospital-of-philadelphia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06541262",
"publication_url": "https://clinicaltrials.gov/study/NCT06541262",
"title": "Phase I/II Study of Silmitasertib (CX-4945) in Combination With Chemotherapy in Children and Young Adults With Relapsed Refractory Solid Tumors",
"has_exemption": false,
"start_date": "2024-10-30",
"completion_date": "2030-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Milton S. Hershey Medical Center",
"sponsor_slug": "milton-s-hershey-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06906887",
"publication_url": "https://clinicaltrials.gov/study/NCT06906887",
"title": "PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer",
"has_exemption": false,
"start_date": "2025-06-17",
"completion_date": "2030-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06926595",
"publication_url": "https://clinicaltrials.gov/study/NCT06926595",
"title": "Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) With Low-Dose Post-Transplant Cyclophosphamide for Prophylaxis of Graft-versus-Host Disease in Hematological Malignancies",
"has_exemption": false,
"start_date": "2026-03-09",
"completion_date": "2030-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Milton S. Hershey Medical Center",
"sponsor_slug": "milton-s-hershey-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07136428",
"publication_url": "https://clinicaltrials.gov/study/NCT07136428",
"title": "A Single Arm, Open-label Phase Ib/II Study of Asciminib in HER2+ Breast Cancer Brain Metastases (ASCENdANT)",
"has_exemption": false,
"start_date": "2026-07-07",
"completion_date": "2030-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06934655",
"publication_url": "https://clinicaltrials.gov/study/NCT06934655",
"title": "Early Reinitiation of Semaglutide Post-Sleeve Gastrectomy in Youth: A Randomized Clinical Trial",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2030-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital Los Angeles",
"sponsor_slug": "childrens-hospital-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07322341",
"publication_url": "https://clinicaltrials.gov/study/NCT07322341",
"title": "A Phase 2 Trial of SX-682 and Atezolizumab in Patients With Advanced NSCLC Who Progressed on Prior Chemotherapy and Immune Checkpoint Inhibitor (ICI) Therapy",
"has_exemption": false,
"start_date": "2026-10-06",
"completion_date": "2030-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07882173",
"publication_url": "https://clinicaltrials.gov/study/NCT07882173",
"title": "Epcoritamab as Consolidative Therapy for Waldenstrom Macroglobulinemia (WM) Treated With a Bruton Tyrosine Kinase Inhibitor (BTKi)",
"has_exemption": false,
"start_date": "2026-10-25",
"completion_date": "2030-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Heart, Lung, and Blood Institute (NHLBI)",
"sponsor_slug": "national-heart-lung-and-blood-institute-nhlbi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07418398",
"publication_url": "https://clinicaltrials.gov/study/NCT07418398",
"title": "Exoskeletal-assisted Walking Combined With Transcutaneous Spinal Cord Stimulation: Effect on Imaging and Serum Biomarkers of Skeletal Muscle Mass and Bone Strength",
"has_exemption": false,
"start_date": "2026-11-01",
"completion_date": "2030-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07860450",
"publication_url": "https://clinicaltrials.gov/study/NCT07860450",
"title": "An Open-label, Multicenter, 2-Part Study: A Phase 1b Dose Selection Followed by a Randomized Phase 3 to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Dostarlimab Plus Carboplatin-Paclitaxel Versus Intravenous Dostarlimab Plus Carboplatin-Paclitaxel in Participants With Primary Advanced or Recurrent Endometrial Cancer (SAPPHIRE)",
"has_exemption": false,
"start_date": "2026-11-12",
"completion_date": "2030-11-05",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03750227",
"publication_url": "https://clinicaltrials.gov/study/NCT03750227",
"title": "Pre-Operative vs. Post-Operative Stereotactic Radiosurgery for Operative Metastatic Brain Tumors",
"has_exemption": false,
"start_date": "2018-11-19",
"completion_date": "2030-11-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221149",
"publication_url": "https://clinicaltrials.gov/study/NCT07221149",
"title": "ROSETTA Gastric-204: A Blinded, Randomized, Phase 2/3 Study of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma",
"has_exemption": false,
"start_date": "2026-03-13",
"completion_date": "2030-11-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06664814",
"publication_url": "https://clinicaltrials.gov/study/NCT06664814",
"title": "An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte Diseases",
"has_exemption": false,
"start_date": "2026-10-25",
"completion_date": "2030-11-11",
"has_results": false,
"results_due": false,
"sponsor_name": "National Human Genome Research Institute (NHGRI)",
"sponsor_slug": "national-human-genome-research-institute-nhgri",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07517705",
"publication_url": "https://clinicaltrials.gov/study/NCT07517705",
"title": "Feasibility of MRD-Adapted Mid-Cycle Low-Dose Radiation Combined With Frontline R-Chemoimmunotherapy in Diffuse Large B-Cell Lymphoma (MRD XRT)",
"has_exemption": false,
"start_date": "2026-06-12",
"completion_date": "2030-11-12",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Nebraska",
"sponsor_slug": "university-of-nebraska",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07808515",
"publication_url": "https://clinicaltrials.gov/study/NCT07808515",
"title": "Phase 2 Platform Trial of Combination Therapies for Participants With Locally Advanced Basal Cell Carcinoma: Master Protocol With Cemiplimab Monotherapy as Comparator Arm",
"has_exemption": false,
"start_date": "2026-10-15",
"completion_date": "2030-11-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06995508",
"publication_url": "https://clinicaltrials.gov/study/NCT06995508",
"title": "Managing Anorexia During Chemoradiation With Olanzapine (MACRO)",
"has_exemption": false,
"start_date": "2025-12-24",
"completion_date": "2030-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Roswell Park Cancer Institute",
"sponsor_slug": "roswell-park-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06627647",
"publication_url": "https://clinicaltrials.gov/study/NCT06627647",
"title": "A Phase III, Randomized, Double-blind, Multicenter, Global Study of Rilvegostomig or Pembrolizumab in Combination With Platinum-based Chemotherapy for the First-line Treatment of Patients With Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer Whose Tumors Express PD-L1 (ARTEMIDE-Lung03)",
"has_exemption": false,
"start_date": "2024-11-27",
"completion_date": "2030-11-18",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06499870",
"publication_url": "https://clinicaltrials.gov/study/NCT06499870",
"title": "Optimizing Treatment and Advanced Multi-Imaging Response Evaluation for Very-High-Risk Prostate Cancer (OPTIMAL) - a Phase II Single Arm Study",
"has_exemption": false,
"start_date": "2024-09-06",
"completion_date": "2030-11-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Sean Sachdev",
"sponsor_slug": "sean-sachdev",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07050186",
"publication_url": "https://clinicaltrials.gov/study/NCT07050186",
"title": "A Single Arm Open-Label Pilot Study to Investigate the Safety and Clinical Activity of Cemiplimab, A Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients With Incurable NUT Carcinoma (NC)",
"has_exemption": false,
"start_date": "2025-08-15",
"completion_date": "2030-11-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06128070",
"publication_url": "https://clinicaltrials.gov/study/NCT06128070",
"title": "Phase 2a Study of Adding Ruxolitinib With Tacrolimus/Methotrexate Regimen for Graft-versus-Host Disease Prophylaxis in Myeloablative Conditioning Hematopoietic Cell Transplantation in Pediatric and Young Adult Patients",
"has_exemption": false,
"start_date": "2024-08-01",
"completion_date": "2030-11-22",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06211764",
"publication_url": "https://clinicaltrials.gov/study/NCT06211764",
"title": "17000139BLC3004: 17000139BLC3004 [SunRISe-5] Ph III HR NMIBC BCG Exp/UR Pap (N=250)",
"has_exemption": false,
"start_date": "2024-04-09",
"completion_date": "2030-11-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07489495",
"publication_url": "https://clinicaltrials.gov/study/NCT07489495",
"title": "A Phase 3, Randomized, Double-blind, Study of Belzutifan + Zanzalintinib Versus Belzutifan + Placebo in Participants With Advanced RCC Who Have Progressed on or After Both PD-1/L1 and VEGF-TKI Therapies in Sequence or in Combination (LITESPARK-034)",
"has_exemption": false,
"start_date": "2026-04-09",
"completion_date": "2030-11-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227597",
"publication_url": "https://clinicaltrials.gov/study/NCT07227597",
"title": "A Phase 1b/2 Open-label Study Evaluating Different MK-6070 and Ifinatamab Deruxtecan (MK-2400)-Based Regimens in First-line Extensive Stage Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-01-29",
"completion_date": "2030-11-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03587272",
"publication_url": "https://clinicaltrials.gov/study/NCT03587272",
"title": "Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease",
"has_exemption": false,
"start_date": "2018-04-17",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Robert Nickel",
"sponsor_slug": "robert-nickel",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04927416",
"publication_url": "https://clinicaltrials.gov/study/NCT04927416",
"title": "The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer",
"has_exemption": false,
"start_date": "2021-10-25",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06185673",
"publication_url": "https://clinicaltrials.gov/study/NCT06185673",
"title": "A Phase 1b/2a, Open-label, Dose Escalation Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia",
"has_exemption": false,
"start_date": "2023-11-28",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Benitec Biopharma, Inc.",
"sponsor_slug": "benitec-biopharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05685004",
"publication_url": "https://clinicaltrials.gov/study/NCT05685004",
"title": "Randomized Phase 2b Study of Safety And Efficacy Of TVI-Brain-1 Combined With Conformal Radiotherapy And Temozolomide Vs Standard Therapy In Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)",
"has_exemption": false,
"start_date": "2023-12-27",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "TVAX Biomedical",
"sponsor_slug": "tvax-biomedical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06169371",
"publication_url": "https://clinicaltrials.gov/study/NCT06169371",
"title": "Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)",
"has_exemption": false,
"start_date": "2023-12-28",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06608927",
"publication_url": "https://clinicaltrials.gov/study/NCT06608927",
"title": "A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 3 Trial of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Treatment-Naive Metastatic Pancreatic Ductal Adenocarcinoma",
"has_exemption": false,
"start_date": "2024-12-13",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Arcus Biosciences, Inc.",
"sponsor_slug": "arcus-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06593093",
"publication_url": "https://clinicaltrials.gov/study/NCT06593093",
"title": "A Bundled Intervention to End Opioid Overdose by Increasing Treatment Uptake Post Emergency Department Discharge",
"has_exemption": false,
"start_date": "2025-02-13",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06671912",
"publication_url": "https://clinicaltrials.gov/study/NCT06671912",
"title": "LoTam: A Randomized, Phase III Clinical Trial of Low-Dose Tamoxifen for Selected Patients With Molecular Low-Risk Early-Stage Breast Cancer",
"has_exemption": false,
"start_date": "2025-02-19",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Alliance for Clinical Trials in Oncology",
"sponsor_slug": "alliance-for-clinical-trials-in-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06649357",
"publication_url": "https://clinicaltrials.gov/study/NCT06649357",
"title": "Comparison Between Bipolar Transurethral Resection of the Prostate and Moses Assisted Holmium Laser Enucleation of the Prostate. A Prospective Randomized Multicentric Study",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Fundacio Puigvert",
"sponsor_slug": "fundacio-puigvert",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06798909",
"publication_url": "https://clinicaltrials.gov/study/NCT06798909",
"title": "Kidney Transplant Preemptive Therapy or Prophylaxis (KPoP) for CMV Prevention in D+R- Recipients",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223424",
"publication_url": "https://clinicaltrials.gov/study/NCT07223424",
"title": "Patient Preference for Subcutaneous vs. Intravenous Immune Therapy (PSI-Immune)",
"has_exemption": false,
"start_date": "2025-11-04",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Diwakar Davar",
"sponsor_slug": "diwakar-davar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227636",
"publication_url": "https://clinicaltrials.gov/study/NCT07227636",
"title": "Phase II Study of Adjuvant Botensilimab in Combination With Balstilimab in Patients With Colorectal Cancer and Persistent Circulating Tumor DNA Following Surgery and Chemotherapy",
"has_exemption": false,
"start_date": "2025-11-07",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07270991",
"publication_url": "https://clinicaltrials.gov/study/NCT07270991",
"title": "Randomized Phase III Trial to Compare Trifluridine/Tipiracil + Fruquintinib Versus Trifluridine/Tipiracil Alone for Metastatic Oeso-gastric Adenocarcinoma",
"has_exemption": false,
"start_date": "2025-12-15",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Federation Francophone de Cancerologie Digestive",
"sponsor_slug": "federation-francophone-de-cancerologie-digestive",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07220616",
"publication_url": "https://clinicaltrials.gov/study/NCT07220616",
"title": "A Phase 1/2, Multicenter, Open-Label, Multi-Cohort, First-in Human Trial of DS3790a, a DXd-ADC Targeting CD37, for Hematological Malignancies",
"has_exemption": false,
"start_date": "2026-01-16",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07194590",
"publication_url": "https://clinicaltrials.gov/study/NCT07194590",
"title": "Equol Supplementation for Improving Vascular Function in Postmenopausal Women With CKD",
"has_exemption": false,
"start_date": "2026-02-19",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07290738",
"publication_url": "https://clinicaltrials.gov/study/NCT07290738",
"title": "TMS for Negative Symptoms in Schizophrenia Spectrum Disorders",
"has_exemption": false,
"start_date": "2026-03-13",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07298902",
"publication_url": "https://clinicaltrials.gov/study/NCT07298902",
"title": "Non-Invasive Deep Brain Neuromodulation for Smoking Cessation",
"has_exemption": false,
"start_date": "2026-04-13",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07559630",
"publication_url": "https://clinicaltrials.gov/study/NCT07559630",
"title": "STRATOS: Single-center Randomized Controlled Trial of Rectal Arterial Embolization vs Band Ligation for the Treatment of Internal hemOrrhoidS",
"has_exemption": false,
"start_date": "2026-05-19",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Jessica K. Stewart, MD",
"sponsor_slug": "jessica-k-stewart-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07793253",
"publication_url": "https://clinicaltrials.gov/study/NCT07793253",
"title": "A Multi-Institutional Phase 2 Evaluation of Daraxonrasib in Recurrent KRAS-Mutant Biliary Tract Cancer",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07859592",
"publication_url": "https://clinicaltrials.gov/study/NCT07859592",
"title": "Labyrinthin Vaccination for Patients With Lung Adenocarcinomas",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07560046",
"publication_url": "https://clinicaltrials.gov/study/NCT07560046",
"title": "Combating Related Epidemics in HCV Through Simplified Testing and Treatment. A Cluster Randomized Trial of Point-of-care Hepatitis C Testing and Treatment Among Key Populations",
"has_exemption": false,
"start_date": "2027-01-20",
"completion_date": "2030-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05616650",
"publication_url": "https://clinicaltrials.gov/study/NCT05616650",
"title": "A Phase II Trial of Focal Ultrahypofractionated Stereotactic Radiation Therapy for the Treatment of Unifocal Prostate Cancer",
"has_exemption": false,
"start_date": "2023-10-19",
"completion_date": "2030-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06569680",
"publication_url": "https://clinicaltrials.gov/study/NCT06569680",
"title": "Phase II Trial of Mosunetuzumab in Patients With Newly Diagnosed Extranodal Marginal Zone Lymphoma (EMZL) (ML44933)",
"has_exemption": false,
"start_date": "2024-11-19",
"completion_date": "2030-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Izidore Lossos, MD",
"sponsor_slug": "izidore-lossos-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06540963",
"publication_url": "https://clinicaltrials.gov/study/NCT06540963",
"title": "Phase II Trial of Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma",
"has_exemption": false,
"start_date": "2024-12-06",
"completion_date": "2030-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Giselle Sholler",
"sponsor_slug": "giselle-sholler",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06640491",
"publication_url": "https://clinicaltrials.gov/study/NCT06640491",
"title": "Intraosseous Vancomycin and Cefazolin vs Intravenous Administration in Primary Total Knee Arthroplasty",
"has_exemption": false,
"start_date": "2025-05-15",
"completion_date": "2030-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The Methodist Hospital Research Institute",
"sponsor_slug": "the-methodist-hospital-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06124157",
"publication_url": "https://clinicaltrials.gov/study/NCT06124157",
"title": "An International Phase 2 Study of Chemotherapy and Tyrosine Kinase Inhibitors With Blinatumomab in Patients With Newly-Diagnosed Philadelphia Chromosome-Positive or ABL-Class Philadelphia Chromosome-Like B-Cell Acute Lymphoblastic Leukemia",
"has_exemption": false,
"start_date": "2025-05-30",
"completion_date": "2030-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07210502",
"publication_url": "https://clinicaltrials.gov/study/NCT07210502",
"title": "Comparing the Side Effects of Low Dose Rate Brachytherapy Against Ultra-Hypofractionated Radiotherapy Using Spacer Gel Treatment in Men With Cambridge Prognostic Groups (CPG) 1 to 3 (NCCN Low to Intermediate Risk) Prostate Cancer",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2030-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Royal Surrey County Hospital NHS Foundation Trust",
"sponsor_slug": "royal-surrey-county-hospital-nhs-foundation-trust",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07439887",
"publication_url": "https://clinicaltrials.gov/study/NCT07439887",
"title": "Phase 1/2, Open-Label, Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease (AURORA)",
"has_exemption": false,
"start_date": "2026-01-28",
"completion_date": "2030-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Ray Therapeutics, Inc.",
"sponsor_slug": "ray-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07102524",
"publication_url": "https://clinicaltrials.gov/study/NCT07102524",
"title": "A Phase 1/2 Open-Label Intrathecal Administration of TSHA-105 to Determine the Safety and Efficacy in Subjects With SLC13A5 Citrate Transporter Disorder Caused by a Mutation in the SLC13A5 Gene.",
"has_exemption": false,
"start_date": "2026-07-15",
"completion_date": "2030-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "TESS Research Foundation",
"sponsor_slug": "tess-research-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07247097",
"publication_url": "https://clinicaltrials.gov/study/NCT07247097",
"title": "ELDORADO: a Randomized Phase II Trial of Elranatamab or Daratumumab in Combination With Lenalidomide, Bortezomib, and Dexamethasone (RVd Lite) in Newly Diagnosed, Transplant Ineligible/Deferred Multiple Myeloma",
"has_exemption": false,
"start_date": "2026-08-01",
"completion_date": "2030-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07593222",
"publication_url": "https://clinicaltrials.gov/study/NCT07593222",
"title": "Synaptic Mechanisms of Intermittent Theta Burst Stimulation for Major Depressive Disorder",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2030-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mclean Hospital",
"sponsor_slug": "mclean-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07796373",
"publication_url": "https://clinicaltrials.gov/study/NCT07796373",
"title": "Nemtabrutinib for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Leukemia (SLL) Refractory to Covalent Bruton Tyrosine Kinase Inhibitor or Pirtobrutinib and Previously Treated With a BCL2 Inhibitor",
"has_exemption": false,
"start_date": "2026-10-25",
"completion_date": "2030-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Heart, Lung, and Blood Institute (NHLBI)",
"sponsor_slug": "national-heart-lung-and-blood-institute-nhlbi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06448286",
"publication_url": "https://clinicaltrials.gov/study/NCT06448286",
"title": "PH Weighted Chemical Exchange Saturation Transfer Based Surgical Resections of Glioblastoma",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2030-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06918132",
"publication_url": "https://clinicaltrials.gov/study/NCT06918132",
"title": "Phase II Single Arm Study of Neoadjuvant Dual Checkpoint Blockade With Programmed Death-ligand 1 (PD1) and Lymphocyte Activation Gene 3 (LAG-3) Inhibition in Resectable Non-Small Cell Lung Cancer (N-PLANC)",
"has_exemption": false,
"start_date": "2025-05-02",
"completion_date": "2030-12-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07226232",
"publication_url": "https://clinicaltrials.gov/study/NCT07226232",
"title": "A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in Veterans",
"has_exemption": false,
"start_date": "2026-08-03",
"completion_date": "2030-12-02",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07225504",
"publication_url": "https://clinicaltrials.gov/study/NCT07225504",
"title": "A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Remibrutinib in Patients With Secondary Progressive Multiple Sclerosis",
"has_exemption": false,
"start_date": "2025-11-11",
"completion_date": "2030-12-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04557462",
"publication_url": "https://clinicaltrials.gov/study/NCT04557462",
"title": "A Multicenter Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan in Adult Participants With Primary IgA Nephropathy Who Have Completed Study CLNP023X2203 or CLNP023A2301",
"has_exemption": false,
"start_date": "2021-09-20",
"completion_date": "2030-12-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07657182",
"publication_url": "https://clinicaltrials.gov/study/NCT07657182",
"title": "A Prospective, Randomized, Assessor-Blinded, Multicenter Study Comparing Avance Nerve Graft and Autograft for Functional Recovery Following Mixed and Motor Peripheral Nerve Reconstruction",
"has_exemption": false,
"start_date": "2026-06-11",
"completion_date": "2030-12-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Axogen Corporation",
"sponsor_slug": "axogen-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07843251",
"publication_url": "https://clinicaltrials.gov/study/NCT07843251",
"title": "A Single-Center, Prospective Trial Evaluating the Efficacy and Tumor Immune Microenvironment Remodeling Induced by Shenqi Fuzheng Injection Combined With Neoadjuvant PD-1 Inhibitors and Platinum-Based Chemotherapy in Resectable Locally Advanced NSCLC",
"has_exemption": false,
"start_date": "2026-10-15",
"completion_date": "2030-12-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Anhui Provincial Cancer Hospital",
"sponsor_slug": "anhui-provincial-cancer-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06875973",
"publication_url": "https://clinicaltrials.gov/study/NCT06875973",
"title": "A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open-Label Pelacarsen in Participants With Elevated Lp(a) and Established ASCVD",
"has_exemption": false,
"start_date": "2025-05-19",
"completion_date": "2030-12-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07594626",
"publication_url": "https://clinicaltrials.gov/study/NCT07594626",
"title": "A Phase Ib/II Basket Study of BMS-986504 in Combination With Pemetrexed for Metastatic Solid Tumors With MTAP Deletion",
"has_exemption": false,
"start_date": "2026-08-21",
"completion_date": "2030-12-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07639528",
"publication_url": "https://clinicaltrials.gov/study/NCT07639528",
"title": "Phase II, Open Label, Non-Randomized, Study of Optimal Preoperative Therapy for Intrahepatic Cholangiocarcinoma (OPTIC)",
"has_exemption": false,
"start_date": "2027-12-10",
"completion_date": "2030-12-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07064460",
"publication_url": "https://clinicaltrials.gov/study/NCT07064460",
"title": "Duke Customized Aortic Aneurysm Repair With Endovascular Stent-grafts - Duke CARES Trial",
"has_exemption": false,
"start_date": "2026-01-13",
"completion_date": "2030-12-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Chandler Long, MD",
"sponsor_slug": "chandler-long-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04929041",
"publication_url": "https://clinicaltrials.gov/study/NCT04929041",
"title": "A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy With or Without Radiation Therapy for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2022-10-07",
"completion_date": "2030-12-12",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06923072",
"publication_url": "https://clinicaltrials.gov/study/NCT06923072",
"title": "A Phase IIa Trial of Baricitinib in the Treatment of Kohlmeier-Degos Disease Patients With Neurological Involvement",
"has_exemption": false,
"start_date": "2026-02-18",
"completion_date": "2030-12-14",
"has_results": false,
"results_due": false,
"sponsor_name": "National Heart, Lung, and Blood Institute (NHLBI)",
"sponsor_slug": "national-heart-lung-and-blood-institute-nhlbi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03769415",
"publication_url": "https://clinicaltrials.gov/study/NCT03769415",
"title": "HARMONY: Harnessing the Analysis of RNA Expression and Molecular Subtype to Optimize Novel TherapY for Metastatic Breast Cancer",
"has_exemption": false,
"start_date": "2018-11-06",
"completion_date": "2030-12-15",
"has_results": false,
"results_due": false,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06753331",
"publication_url": "https://clinicaltrials.gov/study/NCT06753331",
"title": "A Multicenter, Sham-controlled, Randomized Study to Evaluate the Safety, Tolerability, and Clinical Responses Following Stereotactic Intracranial Implantation of DSP-1083 Into Subjects With Parkinson's Disease",
"has_exemption": false,
"start_date": "2024-12-18",
"completion_date": "2030-12-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Sumitomo Pharma America, Inc.",
"sponsor_slug": "sumitomo-pharma-america-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07281456",
"publication_url": "https://clinicaltrials.gov/study/NCT07281456",
"title": "Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's Disease Phase IIa Open-Label Clinical Trial and Associated Mechanistic Studies",
"has_exemption": false,
"start_date": "2025-12-18",
"completion_date": "2030-12-15",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Dental and Craniofacial Research (NIDCR)",
"sponsor_slug": "national-institute-of-dental-and-craniofacial-research-nidcr",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07325604",
"publication_url": "https://clinicaltrials.gov/study/NCT07325604",
"title": "Effect of Neuromuscular Electrical Stimulation on Unilaterial Central Facial Palsy: An Assesorblinded Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2026-02-27",
"completion_date": "2030-12-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Aarhus",
"sponsor_slug": "university-of-aarhus",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07426484",
"publication_url": "https://clinicaltrials.gov/study/NCT07426484",
"title": "A Phase IV Master Protocol of Cosibelimab in Special Populations With Advanced Cutaneous Squamous Cell Carcinoma (CosiMaster)",
"has_exemption": false,
"start_date": "2026-04-23",
"completion_date": "2030-12-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06393374",
"publication_url": "https://clinicaltrials.gov/study/NCT06393374",
"title": "A Phase 3, Randomized, Open-label, Study to Compare the Efficacy and Safety of Adjuvant MK-2870 in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice (TPC) in Participants With Triple-Negative Breast Cancer (TNBC) Who Received Neoadjuvant Therapy and Did Not Achieve a Pathological Complete Response (pCR) at Surgery",
"has_exemption": false,
"start_date": "2024-06-24",
"completion_date": "2030-12-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07281417",
"publication_url": "https://clinicaltrials.gov/study/NCT07281417",
"title": "Neoadjuvant Chemotherapy With or Without Cemiplimab (REGN2810) in Sinonasal Squamous Cell Carcinoma: A Randomized Phase 2 Study",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2030-12-16",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05431088",
"publication_url": "https://clinicaltrials.gov/study/NCT05431088",
"title": "A PHASE 2/3 RANDOMIZED, MULTICENTER STUDY OF OSIVELOTOR ADMINISTERED ORALLY TO ADULT AND ADOLESCENT PARTICIPANTS WITH SICKLE CELL DISEASE",
"has_exemption": false,
"start_date": "2022-09-22",
"completion_date": "2030-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05868226",
"publication_url": "https://clinicaltrials.gov/study/NCT05868226",
"title": "PRE-Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis: A Phase I/II Platform Trial",
"has_exemption": false,
"start_date": "2023-02-15",
"completion_date": "2030-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "QuantumLeap Healthcare Collaborative",
"sponsor_slug": "quantumleap-healthcare-collaborative",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06482801",
"publication_url": "https://clinicaltrials.gov/study/NCT06482801",
"title": "Intra-tumor Delivery of Double Checkpoint Inhibitors, Chemodrug, and/or Bevacizumab Therapy as First Line for Hepatocellular Carcinoma",
"has_exemption": false,
"start_date": "2024-06-10",
"completion_date": "2030-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Second Affiliated Hospital of Guangzhou Medical University",
"sponsor_slug": "second-affiliated-hospital-of-guangzhou-medical-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06619509",
"publication_url": "https://clinicaltrials.gov/study/NCT06619509",
"title": "A Phase II, Single-arm, Open-label, Long-term Safety Rollover Trial of Oral Brigimadlin in Patients With Solid Tumours",
"has_exemption": false,
"start_date": "2024-12-30",
"completion_date": "2030-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06332807",
"publication_url": "https://clinicaltrials.gov/study/NCT06332807",
"title": "An Open-Label, Multiple-Center, Phase I/II Dose Escalation Study for the Safety and Efficacy of NGGT002 in Adults With Classic Phenylketonuria",
"has_exemption": false,
"start_date": "2025-01-10",
"completion_date": "2030-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "NGGT INC.",
"sponsor_slug": "nggt-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06609226",
"publication_url": "https://clinicaltrials.gov/study/NCT06609226",
"title": "An Open-label, Multi-centre, Rollover Study to Characterise Long-term Safety and Efficacy of Etavopivat in Adults, Adolescents and Children Who Have Sickle Cell Disease or Thalassaemia and Have Completed a Treatment Period in an Etavopivat Study",
"has_exemption": false,
"start_date": "2025-01-10",
"completion_date": "2030-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06348394",
"publication_url": "https://clinicaltrials.gov/study/NCT06348394",
"title": "Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion",
"has_exemption": false,
"start_date": "2025-02-25",
"completion_date": "2030-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor Research Institute",
"sponsor_slug": "baylor-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06941272",
"publication_url": "https://clinicaltrials.gov/study/NCT06941272",
"title": "LIGHTBEAM-U01 Substudy 01C: A Phase 1/2 Substudy to Evaluate the Safety and Efficacy of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors",
"has_exemption": false,
"start_date": "2025-05-26",
"completion_date": "2030-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07179939",
"publication_url": "https://clinicaltrials.gov/study/NCT07179939",
"title": "A Multicenter, Open-Label, Phase II Trial of Exploring the Maintenance of Trastuzumab Plus Pyrotinib or Trastuzumab Plus Dalpiciclib and Endocrine Therapy Based on HR Status Following Trastuzumab Rezetecan as Induction Treatment for HER2 Positive Unresectable Locally Recurrent or Metastatic Breast Cancer",
"has_exemption": false,
"start_date": "2025-09-10",
"completion_date": "2030-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Fudan University",
"sponsor_slug": "fudan-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07192952",
"publication_url": "https://clinicaltrials.gov/study/NCT07192952",
"title": "A Phase 3, Single-arm, Open-label Extension Study to Evaluate the Safety of Finerenone in Addition to Standard of Care, in Pediatric Heart Failure Patients, From Birth to 18 Years of Age, With Left Ventricular Systolic Dysfunction (LVSD)",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2030-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bayer",
"sponsor_slug": "bayer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07529405",
"publication_url": "https://clinicaltrials.gov/study/NCT07529405",
"title": "A Phase II Multi-center Randomized Clinical Trial to Determine the Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein (VG712) in Subjects With Mycosis Fungoides (CurbMF Trial)",
"has_exemption": false,
"start_date": "2026-07-30",
"completion_date": "2030-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Virogen Biotechnology Inc.",
"sponsor_slug": "virogen-biotechnology-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07650240",
"publication_url": "https://clinicaltrials.gov/study/NCT07650240",
"title": "A Phase II Randomized Trial of Intermittent Androgen Deprivation Therapy Alone or Combined With [177Lu]Lu-PSMA-617, With or Without Abiraterone and Prednisone, in Patients With Low-Volume Metastatic Hormone-Sensitive Prostate Cancer",
"has_exemption": false,
"start_date": "2026-08-04",
"completion_date": "2030-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07829718",
"publication_url": "https://clinicaltrials.gov/study/NCT07829718",
"title": "Prospective Evaluation of Suzetrigine (Journavx) in Spine Surgery: Signal Characterization and Trial-Design Optimization Using Historical Controls",
"has_exemption": false,
"start_date": "2026-09-13",
"completion_date": "2030-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University",
"sponsor_slug": "ohio-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07568860",
"publication_url": "https://clinicaltrials.gov/study/NCT07568860",
"title": "Sleep-Driven Adaptive Neuromodulation in Lennox-Gastaut Syndrome",
"has_exemption": false,
"start_date": "2027-01-01",
"completion_date": "2030-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07739888",
"publication_url": "https://clinicaltrials.gov/study/NCT07739888",
"title": "A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)",
"has_exemption": false,
"start_date": "2027-12-30",
"completion_date": "2030-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01042379",
"publication_url": "https://clinicaltrials.gov/study/NCT01042379",
"title": "I-SPY Trial (Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis 2)",
"has_exemption": false,
"start_date": "2010-03-01",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "QuantumLeap Healthcare Collaborative",
"sponsor_slug": "quantumleap-healthcare-collaborative",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01280994",
"publication_url": "https://clinicaltrials.gov/study/NCT01280994",
"title": "Hyperpolarized 129Xe MR Imaging of the Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease",
"has_exemption": false,
"start_date": "2011-01-31",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Bastiaan Driehuys",
"sponsor_slug": "bastiaan-driehuys",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01656603",
"publication_url": "https://clinicaltrials.gov/study/NCT01656603",
"title": "A Multicenter Safety Study of Unlicensed, Investigational Cryopreserved Cord Blood Units Manufactured by the National Cord Blood Program and Provided for Unrelated Hematopoietic Stem Cell Transplantation of Pediatric and Adult Patients",
"has_exemption": false,
"start_date": "2012-02-29",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "New York Blood Center",
"sponsor_slug": "new-york-blood-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03915015",
"publication_url": "https://clinicaltrials.gov/study/NCT03915015",
"title": "VAPORHCS/OHSU J: Safety of Clinically Indicated Magnetic Resonance Imaging in Patients With Permanent Pacemakers (PPM) and Implanted Cardioverter Defibrillators (ICDs)",
"has_exemption": false,
"start_date": "2012-07-19",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Oregon Health and Science University",
"sponsor_slug": "oregon-health-and-science-university",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01746836",
"publication_url": "https://clinicaltrials.gov/study/NCT01746836",
"title": "Ponatinib as Second Line Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib, Dasatinib or Nilotinib",
"has_exemption": false,
"start_date": "2013-01-17",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02079662",
"publication_url": "https://clinicaltrials.gov/study/NCT02079662",
"title": "Integrative Oncology Program in Improving Cancer-Related Outcomes in Patients With Stage II or III Breast Cancer Undergoing Radiation Therapy",
"has_exemption": false,
"start_date": "2013-06-13",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02019706",
"publication_url": "https://clinicaltrials.gov/study/NCT02019706",
"title": "Prospective Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Ectopic Cushing Syndrome",
"has_exemption": false,
"start_date": "2014-02-12",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02875314",
"publication_url": "https://clinicaltrials.gov/study/NCT02875314",
"title": "HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors Clinical and Molecular Risk-Tailored Intensive and Compressed Induction Chemotherapy Followed by Consolidation With Randomization to Either Single Cycle or to Three Tandem Cycles of Marrow-Ablative Chemotherapy With Autologous Hematopoietic Progenitor Cell Rescue",
"has_exemption": false,
"start_date": "2015-09-30",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Parth Patel",
"sponsor_slug": "parth-patel",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03096743",
"publication_url": "https://clinicaltrials.gov/study/NCT03096743",
"title": "Evaluating Raised Intracranial Pressure Using MR Elastography",
"has_exemption": false,
"start_date": "2017-01-10",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03868150",
"publication_url": "https://clinicaltrials.gov/study/NCT03868150",
"title": "Assessment of Intra-Operative Atrial Fibrillation Inducibility As a Screening Tool to Prevent Post-Operative Atrial Fibrillation With Prophylaxis Amiodarone",
"has_exemption": false,
"start_date": "2017-03-01",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03138161",
"publication_url": "https://clinicaltrials.gov/study/NCT03138161",
"title": "SAINT: A Phase 1/2 Study of Safe Amounts of IPLIMUMAB, NIVOLUMAB and TRABECTEDIN for Previously Treated Advanced Soft Tissue Sarcoma (STS)",
"has_exemption": false,
"start_date": "2017-04-13",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sarcoma Oncology Research Center, LLC",
"sponsor_slug": "sarcoma-oncology-research-center-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00583817",
"publication_url": "https://clinicaltrials.gov/study/NCT00583817",
"title": "Endovascular Treatment of Thoracic Aortic Disease",
"has_exemption": false,
"start_date": "2018-10-25",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Matthew Eagleton",
"sponsor_slug": "matthew-eagleton",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03935685",
"publication_url": "https://clinicaltrials.gov/study/NCT03935685",
"title": "Pilot Study of Mirtazapine for the Dual Treatment of Depression and Temozolomide-Induced Nausea and Vomiting (CINV) in Newly-Diagnosed High-Grade Glioma Patients on Temozolomide Therapy",
"has_exemption": false,
"start_date": "2019-02-26",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Irvine",
"sponsor_slug": "university-of-california-irvine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03886311",
"publication_url": "https://clinicaltrials.gov/study/NCT03886311",
"title": "The TNT Protocol: A Phase 2 Study Using Talimogene Laherparepvec,Nivolumab and Trabectedin as First, Second/Third Line Therapy for Advanced Sarcoma, Including Desmoid Tumor and Chordoma",
"has_exemption": false,
"start_date": "2019-05-15",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sarcoma Oncology Research Center, LLC",
"sponsor_slug": "sarcoma-oncology-research-center-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04106466",
"publication_url": "https://clinicaltrials.gov/study/NCT04106466",
"title": "Deep Brain Stimulation (DBS) for Treatment Resistant Depression: Exploration of Local Field Potentials (LFPs) With the Medtronic Summit RC+S \"Brain Radio\" System",
"has_exemption": false,
"start_date": "2020-01-21",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Helen Mayberg, MD",
"sponsor_slug": "helen-mayberg-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04166409",
"publication_url": "https://clinicaltrials.gov/study/NCT04166409",
"title": "A Phase 3 Randomized Non-Inferiority Study of Carboplatin and Vincristine Versus Selumetinib (NSC# 748727) in Newly Diagnosed or Previously Untreated Low-Grade Glioma (LGG) Not Associated With BRAFV600E Mutations or Systemic Neurofibromatosis Type 1 (NF1)",
"has_exemption": false,
"start_date": "2020-01-31",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04371913",
"publication_url": "https://clinicaltrials.gov/study/NCT04371913",
"title": "Personalized Second Chance Breast Conservation (PSCBC): A Two Center Prospective Phase II Clinical Study",
"has_exemption": false,
"start_date": "2020-06-30",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04629469",
"publication_url": "https://clinicaltrials.gov/study/NCT04629469",
"title": "Low Field and High Field Magnetic Resonance Imaging Assessments on Pediatric Patients",
"has_exemption": false,
"start_date": "2020-10-01",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Mercy Hospital Kansas City",
"sponsor_slug": "childrens-mercy-hospital-kansas-city",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05101356",
"publication_url": "https://clinicaltrials.gov/study/NCT05101356",
"title": "A Phase 1/2 Open Label Study of LabVax 3(22)-23 and Adjuvant GM-CSF Alone or in Combination With Pembrolizumab in Subjects With Labyrinthin-Positive Adenocarcinomas",
"has_exemption": false,
"start_date": "2021-01-13",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Davis",
"sponsor_slug": "university-of-california-davis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04747626",
"publication_url": "https://clinicaltrials.gov/study/NCT04747626",
"title": "B-SAFER: Branched Stented Anastomosis Frozen Elephant Trunk Repair",
"has_exemption": false,
"start_date": "2021-03-25",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eric Roselli, M. D.",
"sponsor_slug": "eric-roselli-m-d",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04511078",
"publication_url": "https://clinicaltrials.gov/study/NCT04511078",
"title": "Phase II Open-Label Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Head and Neck Cancer During Surgical Procedures",
"has_exemption": false,
"start_date": "2021-04-02",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04614103",
"publication_url": "https://clinicaltrials.gov/study/NCT04614103",
"title": "A Phase 2 Multicenter Study of Autologous Tumor Infiltrating Lymphocytes (TIL or LN-145) in Patients With Metastatic Non-Small-Cell Lung Cancer",
"has_exemption": false,
"start_date": "2021-05-07",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Iovance Biotherapeutics, Inc.",
"sponsor_slug": "iovance-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04844606",
"publication_url": "https://clinicaltrials.gov/study/NCT04844606",
"title": "A Master Protocol for a Phase 3, Multicenter, Open-label, Long-term Extension Study to Evaluate the Long-term Efficacy and Safety of Mirikizumab in Children and Adolescents With Moderate-to-severe Ulcerative Colitis or Crohn's Disease",
"has_exemption": false,
"start_date": "2021-05-26",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07056348",
"publication_url": "https://clinicaltrials.gov/study/NCT07056348",
"title": "Chronic Stimulation of the Motor Ventral Thalamus (VOP/VIM) for Motor Control in Humans",
"has_exemption": false,
"start_date": "2022-05-10",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jorge Gonzalez-Martinez",
"sponsor_slug": "jorge-gonzalez-martinez",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06654180",
"publication_url": "https://clinicaltrials.gov/study/NCT06654180",
"title": "A Comparison of Myopia Control Efficacy in Children With Orthokeratology, Defocus Incorporated Multiple Segment (DIMS) Spectacles, Defocus Incorporated Soft Contact (DISK) Lenses, and Single-vision Spectacles for 12 Months",
"has_exemption": false,
"start_date": "2022-10-21",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kaikai QIU",
"sponsor_slug": "kaikai-qiu",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05344833",
"publication_url": "https://clinicaltrials.gov/study/NCT05344833",
"title": "Post-Autologous Transplant Maintenance With Isatuximab and Lenalidomide in Minimal Residual Disease Positive Multiple Myeloma",
"has_exemption": false,
"start_date": "2023-01-05",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05110742",
"publication_url": "https://clinicaltrials.gov/study/NCT05110742",
"title": "Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological Malignances",
"has_exemption": false,
"start_date": "2024-04-22",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06134167",
"publication_url": "https://clinicaltrials.gov/study/NCT06134167",
"title": "A Prospective, Multicenter, Single-Arm, Open-Label Study to Evaluate the Safety and Effectiveness of the Transdermal Compress Device in Participants With Transfemoral Amputations",
"has_exemption": false,
"start_date": "2024-06-11",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Balmoral Medical company",
"sponsor_slug": "balmoral-medical-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06877312",
"publication_url": "https://clinicaltrials.gov/study/NCT06877312",
"title": "Longitudinal Study to Investigate Different Treatment Protocols of Transcranial Electrical Stimulation for Individuals With Dementia",
"has_exemption": false,
"start_date": "2024-10-09",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Manitoba",
"sponsor_slug": "university-of-manitoba",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06713616",
"publication_url": "https://clinicaltrials.gov/study/NCT06713616",
"title": "Comparative Effectiveness of Racemic Ketamine Versus Esketamine (Spravato®) for Depression",
"has_exemption": false,
"start_date": "2025-01-27",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06960707",
"publication_url": "https://clinicaltrials.gov/study/NCT06960707",
"title": "Prospective Randomized Trial of Two Versus One Week Accelerated Radiotherapy (PRATO)",
"has_exemption": false,
"start_date": "2025-04-29",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06655051",
"publication_url": "https://clinicaltrials.gov/study/NCT06655051",
"title": "Efficacy and Safety of Single Plastic Stent Compared With Fully Covered Self-Expanding Metal Stent on Benign Biliary Stricture Secondary to Chronic Pancreatitis: A Single Center，Prospective，Non-inferiority, Open Label, Randomized, Controlled Trial",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Changhai Hospital",
"sponsor_slug": "changhai-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07050043",
"publication_url": "https://clinicaltrials.gov/study/NCT07050043",
"title": "A Phase III RCT Comparing Low Dose Immunotherapy (Nivolumab) Combined With Standard Chemotherapy vs Standard Chemotherapy as First-line Treatment in Patients With Locally Advanced or Metastatic NSCLC",
"has_exemption": false,
"start_date": "2025-05-19",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dr Arvindran A/L Alaga",
"sponsor_slug": "dr-arvindran-al-alaga",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07148739",
"publication_url": "https://clinicaltrials.gov/study/NCT07148739",
"title": "Ensuring Access to Optimal Therapy in Cystic Fibrosis: The ENACT Study",
"has_exemption": false,
"start_date": "2025-06-10",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Arkansas Children's Hospital Research Institute",
"sponsor_slug": "arkansas-childrens-hospital-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06568549",
"publication_url": "https://clinicaltrials.gov/study/NCT06568549",
"title": "Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf® Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial.",
"has_exemption": false,
"start_date": "2025-06-13",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07079631",
"publication_url": "https://clinicaltrials.gov/study/NCT07079631",
"title": "A Phase I/II, Randomized, Multi-site Trial to Investigate the Efficacy and Safety of BNT314 in Combination With Pumitamig and Chemotherapy in Participants With Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2025-07-18",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06953960",
"publication_url": "https://clinicaltrials.gov/study/NCT06953960",
"title": "A Phase 1/2, Open-Label, Platform Study to Evaluate Safety and Efficacy of the BCL-2 Inhibitor Surzetoclax (ABBV-453) Given as Monotherapy or in Combination With Antimyeloma Regimens in Subjects With Multiple Myeloma",
"has_exemption": false,
"start_date": "2025-07-23",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06381180",
"publication_url": "https://clinicaltrials.gov/study/NCT06381180",
"title": "Wayne Warrior CAnnabis Research and Education: Cannabis and Behavioral Health",
"has_exemption": false,
"start_date": "2025-09-22",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wayne State University",
"sponsor_slug": "wayne-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07841470",
"publication_url": "https://clinicaltrials.gov/study/NCT07841470",
"title": "Corneal Crosslinking for Treatment of Progressive Keratoconus or Ectasia: Randomized Comparison of Pulsed vs. Non-pulsed Treatment",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Price Vision Group",
"sponsor_slug": "price-vision-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07213934",
"publication_url": "https://clinicaltrials.gov/study/NCT07213934",
"title": "WOPPPR: Window of Opportunity Phase I and Phase II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2025-10-08",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Cincinnati",
"sponsor_slug": "university-of-cincinnati",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06934356",
"publication_url": "https://clinicaltrials.gov/study/NCT06934356",
"title": "Shared Subcortical Arousal Systems Across Perceptual Modalities",
"has_exemption": false,
"start_date": "2025-10-13",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227532",
"publication_url": "https://clinicaltrials.gov/study/NCT07227532",
"title": "BWI202405: Assessment of Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the VARIPULSE™ Catheter System",
"has_exemption": false,
"start_date": "2025-10-21",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Biosense Webster, Inc.",
"sponsor_slug": "biosense-webster-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07061977",
"publication_url": "https://clinicaltrials.gov/study/NCT07061977",
"title": "A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab vs Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer",
"has_exemption": false,
"start_date": "2025-11-05",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07196644",
"publication_url": "https://clinicaltrials.gov/study/NCT07196644",
"title": "A Phase 2 Study to Evaluate the Safety and Efficacy of Telisotuzumab Adizutecan for the Treatment of Subjects With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06524544",
"publication_url": "https://clinicaltrials.gov/study/NCT06524544",
"title": "A Phase III Randomized Trial of Pembrolizumab in Combination With Sacituzumab Govitecan-hziy vs Standard of Care in Anti-PD(L)1-Resistant Advanced Urothelial Cancer",
"has_exemption": false,
"start_date": "2025-12-02",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06991101",
"publication_url": "https://clinicaltrials.gov/study/NCT06991101",
"title": "Randomized Phase 2 Trial of Ruxolitinib in Combination With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma.",
"has_exemption": false,
"start_date": "2025-12-03",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baptist Health South Florida",
"sponsor_slug": "baptist-health-south-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06963905",
"publication_url": "https://clinicaltrials.gov/study/NCT06963905",
"title": "Phase Ib Randomized Open-label Trial of Sacituzumab Govitecan Plus Nivolumab or Sacituzumab Govitecan Plus Nivolumab and Relatlimab as Second-line Therapy for Patients With Metastatic Triple Negative Breast Cancer",
"has_exemption": false,
"start_date": "2025-12-29",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07276386",
"publication_url": "https://clinicaltrials.gov/study/NCT07276386",
"title": "Phase 2 Sequential Treatment With Melphalan/HDS Via Percutaneous Hepatic Perfusion Followed by Tebentafusp in the Treatment of Metastatic Uveal Melanoma",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07318493",
"publication_url": "https://clinicaltrials.gov/study/NCT07318493",
"title": "Does Antiseptic Coated Suture Reduce Pancreatic Fistula Rate After Pancreatoduodenectomy: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2026-01-13",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The Cleveland Clinic",
"sponsor_slug": "the-cleveland-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06417190",
"publication_url": "https://clinicaltrials.gov/study/NCT06417190",
"title": "IIT2023-13-BALLAS-VHTMT: Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology",
"has_exemption": false,
"start_date": "2026-01-16",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Leslie Ballas",
"sponsor_slug": "leslie-ballas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07091396",
"publication_url": "https://clinicaltrials.gov/study/NCT07091396",
"title": "Enhancing Functional Recovery With Home-based Transcranial Direct Current Stimulation (tDCS) in Patients With Stroke, Neurodegeneration and Brain Tumors",
"has_exemption": false,
"start_date": "2026-01-16",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07478172",
"publication_url": "https://clinicaltrials.gov/study/NCT07478172",
"title": "Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults withNeuromuscular Disease",
"has_exemption": false,
"start_date": "2026-03-10",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Missouri-Columbia",
"sponsor_slug": "university-of-missouri-columbia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07118618",
"publication_url": "https://clinicaltrials.gov/study/NCT07118618",
"title": "Probenecid, Pannexin 1 Channels for Alcohol Use Disorder",
"has_exemption": false,
"start_date": "2026-03-14",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Brown University",
"sponsor_slug": "brown-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07434726",
"publication_url": "https://clinicaltrials.gov/study/NCT07434726",
"title": "CPReboa: In-hospital Cardiopulmonary Resuscitation With Balloon Occlusion of the Descending Aorta",
"has_exemption": false,
"start_date": "2026-04-14",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Insel Gruppe AG, University Hospital Bern",
"sponsor_slug": "insel-gruppe-ag-university-hospital-bern",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07230990",
"publication_url": "https://clinicaltrials.gov/study/NCT07230990",
"title": "Mechanisms Of Orbitofrontal Stimulation in Depression (MOOD)",
"has_exemption": false,
"start_date": "2026-04-15",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Subha Subramanian",
"sponsor_slug": "subha-subramanian",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07495995",
"publication_url": "https://clinicaltrials.gov/study/NCT07495995",
"title": "A Single-center, Phase II Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Effect of S-adenosyl-L-methionine (SAMe) in Prevention of Hepatocellular Carcinoma Among Patients With Metabolic Dysfunction-associated Steatotic Liver Diseases (MASLD)-Related Cirrhosis",
"has_exemption": false,
"start_date": "2026-04-15",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Cedars-Sinai Medical Center",
"sponsor_slug": "cedars-sinai-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07531745",
"publication_url": "https://clinicaltrials.gov/study/NCT07531745",
"title": "Phase 1-2, Open-Label, Single and Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION337 in Patients With Dravet Syndrome",
"has_exemption": false,
"start_date": "2026-05-21",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ionis Pharmaceuticals, Inc.",
"sponsor_slug": "ionis-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07594652",
"publication_url": "https://clinicaltrials.gov/study/NCT07594652",
"title": "Use of JornayPM® to Treat ADHD in Pediatric Epilepsy",
"has_exemption": false,
"start_date": "2026-05-29",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hugo W. Moser Research Institute at Kennedy Krieger, Inc.",
"sponsor_slug": "hugo-w-moser-research-institute-at-kennedy-krieger-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07608432",
"publication_url": "https://clinicaltrials.gov/study/NCT07608432",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of DYNE-251 Administered Intravenously in Ambulatory Male Participants 4 to 18 Years of Age With Duchenne Muscular Dystrophy Amenable to Exon-51 Skipping",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dyne Therapeutics",
"sponsor_slug": "dyne-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07416188",
"publication_url": "https://clinicaltrials.gov/study/NCT07416188",
"title": "Phase 1/Phase 2 Open Label Trial of a Novel Indenoisoquinolone C-MYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma",
"has_exemption": false,
"start_date": "2026-07-15",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Neurological Disorders and Stroke (NINDS)",
"sponsor_slug": "national-institute-of-neurological-disorders-and-stroke-ninds",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07483255",
"publication_url": "https://clinicaltrials.gov/study/NCT07483255",
"title": "A Phase II Trial of Fetal Embolization for Vein of Galen Malformation",
"has_exemption": false,
"start_date": "2026-07-20",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Darren Orbach",
"sponsor_slug": "darren-orbach",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07628062",
"publication_url": "https://clinicaltrials.gov/study/NCT07628062",
"title": "Open-Label, Single-Arm Phase 2 Study Of Nogapendekin Alfa Inbakicept, PD-L1 T-HaNK, And Bevacizumab And Randomized Phase 2B Study Of Nogapendekin Alfa Inbakicept, Bevacizumab, And Tumor Treatment Fields With Or Without PD-L1 T-HaNK In Participants With Recurrent Or Progressive Glioblastoma",
"has_exemption": false,
"start_date": "2026-07-22",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ImmunityBio, Inc.",
"sponsor_slug": "immunitybio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06683534",
"publication_url": "https://clinicaltrials.gov/study/NCT06683534",
"title": "Use of Quercetin to Increase Resiliency to Palmitic Acid in the Human Microvasculature",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2030-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}